Nanion Technologies Announces the Winners of the SURFE²R Grant Award ? a Platform for Membrane Transporter Research and Screening

Nanion today announced two winners of the SURFE²R N1 grant award. Dr. Camilo Perez and Dr. Dimitrios Fotiadis convinced the grant committee with their proposed research projects

ID: 1553531
recent pressrelease next pressrelease

(PresseBox) - Transporter proteins are gaining increasing interest in academic science and as therapeutic targets. Nanion?s two platforms, SURFE

Earlier this year, Nanion announced the SURFEecision.

Dr. Maria Barthmes, SURFE

The committee has therefore decided to grant two applicants the use of the SURFE

The SURFE

Prof. Dr. Camilo Perez

Biozentrum (The Center for Molecular Life Sciences), University of Basel, Switzerland

Title of the project: ?Novel cell wall synthesis blockers: characterization of inhibitory nanobodies by SSM-based electrophysiology?

Prof. Dr. Dimitrios Fotiadis

Institute for Biochemistry and Molecular Medicine, University of Bern, Switzerland

Title of the project: ?Electrogenic transporters from the solute carrier (SLC) families 7, 15 and 16: From function to deorphanization?

We congratulate the winners and are looking forward to seeing exciting results in the coming year.

Nanion Technologies is a leading provider of instrumentation for ion channel drug discovery and screening. Founded in 2002, Nanion has grown over the last 17 years to a company with over 100 employees worldwide. With headquarters in Munich, Germany, Nanion has subsidiaries in the USA, Japan, China and Denmark, as well as distribution partners in seven other countries.

Nanion?s team has developed and successfully established four generations of automated patch clamp instruments for sophisticated and high throughput applications in ion channel research and drug discovery (Port-a-Patch, Patchliner and SyncroPatch product families).

Further product lines are for cell monitoring and cardiotoxicity screening (CardioExcyte 96), for parallel bilayer recordings (Orbit family), and for parallel membrane transporter protein recordings (SURFE

For more information, please visit www.nanion.de



More information:
http://https://www.realwire.com/releases/Advisory-Firm-Avonhurst-Secures-High-Profile-Citigroup-Hire https://www.realwire.com/releases/Accounts-Payable-Department-Spending-Inordinate-Time-Fixing-Invoicing-Errors https://fromocean.com/wholesale/fashion-jewelry/br



Keywords (optional):



Company information / Profile:

Nanion Technologies is a leading provider of instrumentation for ion channel drug discovery and screening. Founded in 2002, Nanion has grown over the last 17 years to a company with over 100 employees worldwide. With headquarters in Munich, Germany, Nanion has subsidiaries in the USA, Japan, China and Denmark, as well as distribution partners in seven other countries.Nanion?s team has developed and successfully established four generations of automated patch clamp instruments for sophisticated and high throughput applications in ion channel research and drug discovery (Port-a-Patch, Patchliner and SyncroPatch product families).Further product lines are for cell monitoring and cardiotoxicity screening (CardioExcyte 96), for parallel bilayer recordings (Orbit family), and for parallel membrane transporter protein recordings (SURFE²R).For more information, please visit www.nanion.de

PressRelease by

Requests:



PressContact / Agency:



published by: PresseBox
print pressrelease  send to a friend  

Date: 10/31/2019 - 06:20
Language: English
News-ID 1553531
Character count: 3048
Kontakt-Informationen:
Firma: Nanion Technologies GmbH
Ansprechpartner: Feedback to businesspress24.com about Pressrelease-id:
Stadt: München
Telefon:

Meldungsart:
Versandart:
Freigabedatum:
Comments:



Number of hits: 807

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 74


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.